Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2005
02/10/2005US20050031556 Cosmetic or dermatological light-protective formulation comprising a hydroxybenzophenone and a benzoxazole derivative
02/10/2005US20050031555 Topically applying a stable mixture of indomethacin and moisturizing lotion to skin; storage stability
02/10/2005US20050031548 Suspension aerosol formulations of pharmaceutical products
02/10/2005US20050031546 Heat pressing a mixture of an active ingredient with abuse potential, a high strength polymer, and a wax into a controlled release dosage form
02/10/2005US20050031537 Multifunctional COX-2 inhibitors
02/10/2005US20050029705 Extrusion die
02/10/2005DE3823105B4 Dolastatin 10, Verfahren zu seiner Gewinnung, und es enthaltende pharmazeutische Zusammensetzungen Dolastatin 10, process for its production, and pharmaceutical compositions containing it
02/10/2005DE19906152B4 Wirkstoffhaltige Laminate für Transdermalsysteme Active substance laminates for transdermal
02/10/2005DE19845403B4 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Propanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use
02/10/2005DE10333448A1 Use of quinones and their derivatives as urease inhibitors, particularly for treating infections with urease-producing bacteria, e.g. Helicobacter pylori
02/10/2005DE10332712A1 Verwendung von c9,t11-Isomeren der konjugierten Linolsäure Use of c9, t11 isomer of conjugated linoleic acid
02/10/2005DE10332487A1 Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen Ambroxol for the treatment of chronic nociceptive pain
02/10/2005DE10332486A1 Ambroxol für die Behandlung akuter Schmerzen Ambroxol for the treatment of acute pain
02/10/2005DE10331750A1 Therapy and/or prophylaxis of cranial-cerebral trauma, cerebral ischemia or Alzheimer's disease, using frankincense-based active agents, e.g. boswellic acid or hydrogenated derivatives
02/10/2005DE10254995B4 Verfahren zur enzymatischen Reduktion von NAD und NADP Process for the enzymatic reduction of NAD and NADP
02/10/2005DE10221194B4 Hyaluronidasehaltiges Hautpflegemittel Hyaluronidasehaltiges skin care products
02/10/2005DE10158447B4 Ascorbinsäure-Solubilisat Ascorbic acid-solubilized
02/10/2005CA2575760A1 Selected betaines and their uses
02/10/2005CA2549025A1 Substituted indole-o-glucosides
02/10/2005CA2549022A1 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
02/10/2005CA2549017A1 Substituted indazole-o-glucosides
02/10/2005CA2549015A1 Substituted fused heterocyclic c-glycosides
02/10/2005CA2537331A1 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
02/10/2005CA2535225A1 Methods for the stabilization of atorvastatin
02/10/2005CA2534690A1 Composition for the treatment of vitiligo
02/10/2005CA2534660A1 Single unit pharmaceutical composition comprising a mixture of a fibrate and an homocysteine reducing agent
02/10/2005CA2534649A1 Bicyclic imidazol derivatives against flaviviridae
02/10/2005CA2534473A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
02/10/2005CA2534464A1 Benzoxazepine compound
02/10/2005CA2534460A1 Benzylamine derivative
02/10/2005CA2534451A1 Angiotensin ii receptor blocker derivatives
02/10/2005CA2534432A1 Methods for treating diabetes and related disorders using pde10a inhibitors
02/10/2005CA2534371A1 Dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
02/10/2005CA2534354A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
02/10/2005CA2534327A1 Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
02/10/2005CA2534295A1 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts
02/10/2005CA2534267A1 Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
02/10/2005CA2534263A1 Phenylazole compounds, production process and antioxidants
02/10/2005CA2534238A1 Transdermal warfarin-containing delivery system
02/10/2005CA2534214A1 Treatment of ocular disease
02/10/2005CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
02/10/2005CA2534129A1 Spray drying processes for forming solid amorphous dispersions of drugs and polymers
02/10/2005CA2534127A1 Substituted benzothiophene compounds and uses thereof
02/10/2005CA2534075A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
02/10/2005CA2534074A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
02/10/2005CA2534073A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
02/10/2005CA2534067A1 Use of a bigaunide derivative for protecting skin against uvb radiation
02/10/2005CA2534038A1 Inhibitors of akt activity
02/10/2005CA2534033A1 Complex matrix for biomedical use
02/10/2005CA2534008A1 Methods of therapeutic treatment using amounts of retinoid components
02/10/2005CA2534005A1 Methods of therapeutic treatment using amounts of retinoid components
02/10/2005CA2533966A1 Nucleobase phosphonate analogs for antiviral treatment
02/10/2005CA2533901A1 Piperazine derivatives and their use as therapeutic agents
02/10/2005CA2533900A1 Pyridyl derivatives and their use as therapeutic agents
02/10/2005CA2533898A1 Pyridyl derivatives and their use as therapeutic agents
02/10/2005CA2533897A1 Pyridazine derivatives and their use as therapeutic agents
02/10/2005CA2533893A1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
02/10/2005CA2533892A1 Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds
02/10/2005CA2533870A1 Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
02/10/2005CA2533824A1 Bicyclic compounds and compositions as pdf inhibitors
02/10/2005CA2533774A1 Compounds and compositions as protein kinase inhibitors
02/10/2005CA2533752A1 Use of quinazoline tyrosine kinase inhibitors in the treatment of inflammatory processes
02/10/2005CA2533720A1 Antimycosic nail varnish
02/10/2005CA2533715A1 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
02/10/2005CA2533684A1 Substituted pyridones and pyrimidinones with antiinflammatory properties
02/10/2005CA2533673A1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
02/10/2005CA2533672A1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
02/10/2005CA2533636A1 Novel 6-phenylphenanthridines
02/10/2005CA2533635A1 Novel 6-phenylphenantridines
02/10/2005CA2533600A1 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation
02/10/2005CA2533554A1 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders
02/10/2005CA2533506A1 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents
02/10/2005CA2533504A1 Quinoneimines of malonic acid diamides
02/10/2005CA2533492A1 Use of 3,7-diazabicyclo[3,3,1]nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
02/10/2005CA2533475A1 Neuroprotective benzo[1,3]oxathol-2-ones
02/10/2005CA2533474A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
02/10/2005CA2533423A1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer
02/10/2005CA2533345A1 Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
02/10/2005CA2533287A1 Compounds for modulating cell proliferation
02/10/2005CA2533150A1 A doxycycline metal complex in a solid dosage form
02/10/2005CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
02/10/2005CA2532904A1 Transdermal therapeutic system containing a pramipexol active agent
02/10/2005CA2532774A1 Alkaline salts of proton pump inhibitors
02/10/2005CA2532505A1 5-ht2b receptor antagonists
02/10/2005CA2532382A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
02/10/2005CA2532251A1 Cci-779 lyophilized formulations
02/10/2005CA2531333A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
02/10/2005CA2531294A1 2-methylene-19-nor-20(s)-25-methyl-1.alpha.-hydroxycalciferol and its uses
02/10/2005CA2531279A1 Treatment and preventi0n of cardiovascular events
02/10/2005CA2531140A1 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors
02/10/2005CA2529662A1 Aryl dicarboxamides
02/10/2005CA2529521A1 Combination of drugs for the treatment of neoplasms
02/10/2005CA2529123A1 Hydrazide derivatives as prostaglandin receptors modulators
02/10/2005CA2528834A1 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
02/10/2005CA2528592A1 Novel lincomycin derivatives possessing antimicrobial activity
02/10/2005CA2527861A1 Alkynyl aryl carboxamides
02/10/2005CA2526829A1 Immunomodulation with novel pharmaceutical compositions
02/10/2005CA2526589A1 Processed fat composition for preventing/ameliorating lifestyle-related diseases
02/10/2005CA2520546A1 Benzo[1,2,5]thiadiazole compounds
02/10/2005CA2514466A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
1 ... 4792 4793 4794 4795 4796 4797 4798 4799 4800 4801 4802 4803 4804 4805 4806 4807 4808 4809 4810 4811 4812 ... 7860